• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Severe psoriasis linked with poorly controlled blood pressure

byShirin BajajandAdam Whittington
October 19, 2014
in Chronic Disease, Dermatology
Reading Time: 2 mins read
Severe psoriasis linked with poorly controlled blood pressure
Share on FacebookShare on Twitter

1. Psoriasis severity was associated with an increased likelihood of uncontrolled hypertension.

Evidence Rating Level: 2 (Good)

Study Rundown: Psoriasis is a common chronic inflammatory disease in which changes in cell turnover cause the formation of thick scaly plaques on the skin. Previous studies have demonstrated increased risk for cardiovascular disease in patients with psoriasis. The authors of this study aimed to assess the relationship of varying degrees of psoriasis on blood pressure (BP) control. Amongst patients with previously diagnosed hypertension (HTN, high blood pressure), there was a positive dose-response relationship between psoriasis severity and poorly controlled BP. While the study’s strength was its large cohort, the outcome of “uncontrolled HTN” was made after only a single BP measurement rather than an aggregate of multiple readings, which may have limited the study’s accuracy. Future studies are needed to better elucidate the pathophysiology linking blood pressure and psoriasis.

Click to read the study in JAMA Dermatology

Relevant Reading: Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis

In-Depth [cross-sectional study]: 1322 patients were chosen from The Health Improvement Network (THIN) database; they were aged 25-64 and carried a diagnosis of both HTN and psoriasis. 11,977 age- and practice-matched controls also with HTN but without psoriasis were selected for comparison. 51.4%, 35.3%, 13.1% of the psoriasis cohort had mild, moderate, or severe disease, respectively. After accounting for confounders including age, sex, body mass index, duration of HTN, HTN severity and treatment, history of cyclosporine or corticosteroid use, the authors found a statistically significant association between psoriasis severit and uncontrolled HTN ≥140/90 (adjusted odds ratio (aOR) 0.97; 95% CI, 0.82-1.14 for mild psoriasis; and aOR, 1.48; 95% CI, 1.08-2.04 for severe psoriasis; P = .01).

RELATED REPORTS

Telehealth yields modest improvements in diabetes outcomes 

Early control of systolic blood pressure following intracerebral hemorrhage may improve functional recovery

New guidelines limit hypertension treatment in adults over 65

More from this author: Tech-aided surveillance of patients at high risk for melanoma aids early diagnosis, Indoor tanning linked to high skin cancer risk in US and abroad, Free drug samples may alter prescription habits of dermatologists, Atopic dermatitis may be more persistent than previously understood

Image: CC/Wiki/MediaJet

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: hypertensionpsoriasis
Previous Post

VEGFR-targeted ultrasound may improve detection of pancreatic cancer

Next Post

Incidence of esophageal cancer subtypes vary drastically globally and by gender

RelatedReports

Chronic Disease

Telehealth yields modest improvements in diabetes outcomes 

June 22, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Early control of systolic blood pressure following intracerebral hemorrhage may improve functional recovery

March 24, 2026
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

New guidelines limit hypertension treatment in adults over 65

March 16, 2026
UTI associated with increased risk of preeclampsia
Chronic Disease

Elevated blood pressure at discharge from delivery hospitalization predicts earlier admission postpartum

February 23, 2026
Next Post
Incidence of esophageal cancer subtypes vary drastically globally and by gender

Incidence of esophageal cancer subtypes vary drastically globally and by gender

Parents desensitized with increasing exposure to movie violence/sex

Parents desensitized with increasing exposure to movie violence/sex

Out-of-hospital medication error rate unchanged in young children

Out-of-hospital medication error rate unchanged in young children

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.